LEADERSHIP PHARMAKON Trademark
Trademark Overview
On Friday, January 30, 2026, a trademark application was filed for LEADERSHIP PHARMAKON with the United States Patent and Trademark Office. The USPTO has given the LEADERSHIP PHARMAKON trademark a serial number of 99624143. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, January 30, 2026. This trademark is owned by Surko Consulting, LLC. The LEADERSHIP PHARMAKON trademark is filed in the Education & Entertainment Services category with the following description:
Publication of newsletters
General Information
| Serial Number | 99624143 |
| Word Mark | LEADERSHIP PHARMAKON |
| Filing Date | Friday, January 30, 2026 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Friday, January 30, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Publication of newsletters |
| Translation of Words in Mark | The English translation of the Greek wording Pharmakon in the mark is remedy or poison. |
Classification Information
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 30, 2026 |
| Primary Code | 041 |
| First Use Anywhere Date | Wednesday, January 14, 2026 |
| First Use In Commerce Date | Wednesday, January 14, 2026 |
Trademark Owner History
| Party Name | Surko Consulting, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Brooklyn, NY 11205 |
Trademark Events
| Event Date | Event Description |
| Friday, January 30, 2026 | NEW APPLICATION ENTERED |
| Friday, January 30, 2026 | APPLICATION FILING RECEIPT MAILED |
